Daniel J. Wallace
Daniel J. Wallace publishes mostly in Rheumatology, Immunology and Pathology and Forensic Medicine, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #56,873 of 7,710,434 ranked researchers
- Rank in United States
- #21,963 of 1,627,098
- Works
- 780
- Citations
- 43k
- Citations per work
- 55.4
What does Daniel J. Wallace research?
Daniel J. Wallace's work is mostly in Medicine (52%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences40952.4%
- Medicine40952.4%
- Everything else30739.4%
- Life Sciences648.2%
- 1Rheumatology33% of their works
- 2Immunology8% of their works
- 3Pathology and Forensic Medicine8% of their works
- 4Radiology, Nuclear Medicine and Imaging4% of their works
- 5Psychiatry and Mental health4% of their works
- 6Physiology3% of their works
Research topics
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Monoclonal and Polyclonal Antibodies Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Systemic Sclerosis and Related Diseases
- Multiple Sclerosis Research Studies
- T-cell and B-cell Immunology
- Liver Diseases and Immunity
Which keywords describe Daniel J. Wallace's research?
The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Inflammation, Rheumatoid Arthritis, Treatment, Diagnostic Criteria and Epidemiology.
- Primary Biliary Cirrhosis
- Autoimmune Hepatitis
- Multiple Sclerosis
- Fibrosis
- Chronic Fatigue Syndrome
- Fc Receptors
- Epidemiology
- Treatment
- Inflammation
- Antiphospholipid Syndrome
- Autoantibodies
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Diagnostic Criteria
- Immunosuppressive Therapy
- Therapeutic Antibodies
- Fibromyalgia
- Systemic Sclerosis
- Neuromyelitis Optica
- Foxp3
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies6323 topics
- Antiphospholipid Syndrome4421 topic
- Systemic Lupus Erythematosus4421 topic
- Inflammation1301 topic
- Rheumatoid Arthritis1301 topic
- Treatment1272 topics
- Diagnostic Criteria1212 topics
- Epidemiology1062 topics
- Immunosuppressive Therapy992 topics
- Fc Receptors741 topic
- Therapeutic Antibodies741 topic
- Chronic Fatigue Syndrome671 topic
- Fibromyalgia671 topic
- Fibrosis601 topic
- Systemic Sclerosis601 topic
- Multiple Sclerosis541 topic
- Neuromyelitis Optica541 topic
- Autoimmune Hepatitis391 topic
- Foxp3391 topic
- Primary Biliary Cirrhosis391 topic
- TGF-ß391 topic
Where does Daniel J. Wallace work?
Daniel J. Wallace's main affiliation in the publication record is Cedars-Sinai Medical Center, United States.
How many publications and citations does Daniel J. Wallace have?
OpenAlex counts 780 works and 43,249 citations for Daniel J. Wallace, an h-index of 95, ranking #56,873 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Daniel J. Wallace
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel J. Wallace. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.